Literature DB >> 24275188

Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia.

Diva D De León1, Charles A Stanley.   

Abstract

Hyperinsulinemic hypoglycemia is the most common cause of persistent hypoglycemia in children and adults. The diagnosis of hyperinsulinemic hypoglycemia relies on the evaluation of the biochemical profile at the time of hypoglycemia, however, contrary to common perception, plasma insulin is not always elevated. Thus, the diagnosis must often be based on the examination of other physiologic manifestations of excessive insulin secretion, such as suppression of glycogenolysis, lipolysis and ketogenesis, which can be inferred by the finding of a glycemic response to glucagon, and the suppression of plasma free fatty acids and beta-hydroxybutyrate concentrations during hypoglycemia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  beta cells; hyperinsulinism; hypoglycemia; insulinoma; pancreas

Mesh:

Substances:

Year:  2013        PMID: 24275188      PMCID: PMC4141553          DOI: 10.1016/j.beem.2013.06.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  32 in total

Review 1.  DYNAMICS OF INSULIN SECRETION IN HYPOGLYCEMIA.

Authors:  R S YALOW; S A BERSON
Journal:  Diabetes       Date:  1965-06       Impact factor: 9.461

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

Review 3.  Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.

Authors:  Diva D De León; Charles A Stanley
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-01

4.  Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA.

Authors:  D Chevenne; A Letailleur; F Trivin; D Porquet
Journal:  Clin Chem       Date:  1998-02       Impact factor: 8.327

5.  World Health Organization International Standards for highly purified human, porcine and bovine insulins.

Authors:  A F Bristow; R E Das; D R Bangham
Journal:  J Biol Stand       Date:  1988-07

6.  C-peptide analysis in diagnosis of factitial hypoglycemia in an insulin-dependent diabetic.

Authors:  F J Service; A Rubenstein; D L Horwitz
Journal:  Mayo Clin Proc       Date:  1975-12       Impact factor: 7.616

Review 7.  Hyperinsulinism in infancy and childhood: when an insulin level is not always enough.

Authors:  Andrew A Palladino; Michael J Bennett; Charles A Stanley
Journal:  Clin Chem       Date:  2007-12-21       Impact factor: 8.327

8.  Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma.

Authors:  P C Kao; R L Taylor; F J Service
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

Review 9.  Insulin autoimmune syndrome in Japan.

Authors:  Y Hirata; Y Uchigata
Journal:  Diabetes Res Clin Pract       Date:  1994-10       Impact factor: 5.602

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  14 in total

Review 1.  Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management.

Authors:  Charles A Stanley; Paul J Rozance; Paul S Thornton; Diva D De Leon; Deborah Harris; Morey W Haymond; Khalid Hussain; Lynne L Levitsky; Mohammad H Murad; Rebecca A Simmons; Mark A Sperling; David A Weinstein; Neil H White; Joseph I Wolfsdorf
Journal:  J Pediatr       Date:  2015-03-25       Impact factor: 4.406

Review 2.  Congenital hyperinsulinism disorders: Genetic and clinical characteristics.

Authors:  Elizabeth Rosenfeld; Arupa Ganguly; Diva D De Leon
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-08-14       Impact factor: 3.908

Review 3.  Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.

Authors:  Arianna Maiorana; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2017-06-27       Impact factor: 4.982

Review 4.  Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.

Authors:  Matthew R Timlin; Alexander B Black; Heather M Delaney; Renée I Matos; Candace S Percival
Journal:  Pediatr Cardiol       Date:  2017-06-22       Impact factor: 1.655

Review 5.  Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review.

Authors:  Kevin Perge; Marc Nicolino
Journal:  Rev Endocr Metab Disord       Date:  2022-08-23       Impact factor: 9.306

6.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

7.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

8.  A novel case of compound heterozygous congenital hyperinsulinism without high insulin levels.

Authors:  Cassandra Brady; Andrew A Palladino; Iris Gutmark-Little
Journal:  Int J Pediatr Endocrinol       Date:  2015-07-15

9.  Clinical practice guidelines for congenital hyperinsulinism.

Authors:  Tohru Yorifuji; Reiko Horikawa; Tomonobu Hasegawa; Masanori Adachi; Shun Soneda; Masanori Minagawa; Shinobu Ida; Takeo Yonekura; Yoshiaki Kinoshita; Yutaka Kanamori; Hiroaki Kitagawa; Masato Shinkai; Hideyuki Sasaki; Masaki Nio
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

Review 10.  Congenital hyperinsulinism: current status and future perspectives.

Authors:  Tohru Yorifuji
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.